Financhill
Back

Seritage Growth Properties Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
23

SRG
Seritage Growth Properties

Last Price:
4.62
Seasonality Move:
17.59%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.45
Seasonality Move:
3.65%
Sell
23
Seritage Growth Properties (SRG) is a Sell

Is Seritage Growth Properties a Buy, Sell or Hold?

  • The current Seritage Growth Properties [SRG] share price is $4.64. The Score for SRG is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • SRG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SRG Stock Price Chart

What is Seritage Growth Properties's stock price today?

  • The Seritage Growth Properties share price today is $4.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRG is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.66 Sell
Relative Strength Index (14 RSI): 11.6 Sell
Chaikin Money Flow: -102922 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.83 - 5.75) Sell
Bollinger Bands (100): (6.47 - 10.09) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

SRG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.79 Sell
20-day SMA: 5.1 Sell
50-day SMA: 7.15 Sell
200-day SMA: 8.36 Sell
8-day EMA: 4.83 Sell
20-day EMA: 5.31 Sell
50-day EMA: 6.59 Sell
200-day EMA: 8.23 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Seritage Growth Properties Earnings Growth & SRG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Seritage Growth Properties Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):